We demonstrated primarily that deguelin decreased HK2 and glycolysis in NSCLC and that Akt signaling pathway was confirmed to be crucial for deguelin-mediated HK2 expression and glycolysis regulation. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.